Showing results (1-10 of 13) with videos related to
Sort By:
Pageof 2
Current Opinion in Investigational Drugs (London, England : 2000)|December 13, 2002
TAK-677 (Dainippon/Takeda)Stephan FranckeBMC Proceedings|March 1, 2012
Rare variant collapsing in conjunction with mean log p-value and gradient boosting approaches applied to Genetic Analysis Workshop 17 dataYauheniya Cherkas, Nandini Raghavan, Stephan Francke, et al.BMC Genomics|September 1, 2023
Genome-wide association study of abnormal elevation of ALT in patients exposed to atabecestatQingqin S Li, Stephan Francke, Jan Snoeys, et al.Cancer Chemotherapy and Pharmacology|March 18, 2006
Effect of CYP2D6 genetic polymorphism on the population pharmacokinetics of tipifarnibJuan Jose Perez-Ruixo, Peter Zannikos, Vural Ozdemir, et al.Clinical Pharmacology in Drug Development|May 19, 2018
Tramadol Hydrochloride at Steady State Lacks Clinically Relevant QTc Interval Increases in Healthy AdultsJoseph Massarella, Jay Ariyawansa, Jaya Natarajan, et al.Journal of Clinical Pharmacology|April 8, 2014
The effect of UGT2B7*2 polymorphism on the pharmacokinetics of OROS® hydromorphone in Taiwanese subjectsJoris Vandenbossche, Henry Richards, Stephan Francke, et al.Journal of Clinical Pharmacology|April 2, 2015
In vitro metabolism of canagliflozin in human liver, kidney, intestine microsomes, and recombinant uridine diphosphate glucuronosyltransferases (UGT) and the effect of genetic variability of UGT enzymes on the pharmacokinetics of canagliflozin in humansStephan Francke, Rao N V S Mamidi, Bhavna Solanki, et al.Pharmacogenetics and Genomics|November 3, 2015
A candidate-gene association study of topiramate-induced weight loss in obese patients with and without type 2 diabetes mellitusQingqin S Li, James M Lenhard, Yiping Zhan, et al.Diabetes|February 28, 2004
A genome-wide scan for childhood obesity-associated traits in French families shows significant linkage on chromosome 6q22.31-q23.2David Meyre, Cécile Lecoeur, Jérôme Delplanque, et al.Pharmacogenomics|December 1, 2015
The role of ADME pharmacogenomics in early clinical trials: perspective of the Industry Pharmacogenomics Working Group (I-PWG)Larry Tremaine, William Brian, Terrye DelMonte, et al.Pageof 2